BIO-TECHNE Corp Stock Repurchased and Retired During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIO-TECHNE Corp stock repurchased and retired during period, value for the quarter ending 2025-09-30 was $24.00K.
- BIO-TECHNE Corp stock repurchased and retired during period, value for the quarter ending 2025-03-31 was $100.05M.
- BIO-TECHNE Corp stock repurchased and retired during period, value for the quarter ending 2024-12-31 was $75.63M, a 5.51% decline year-over-year.
- BIO-TECHNE Corp stock repurchased and retired during period, value for the quarter ending 2023-12-31 was $80.04M.
- BIO-TECHNE Corp stock repurchased and retired during period, value for fiscal 2026 was $41.67M, a 84.98% decline from fiscal 2025.
- BIO-TECHNE Corp stock repurchased and retired during period, value for fiscal 2025 was $277.54M, a 246.74% increase from fiscal 2024.
- BIO-TECHNE Corp stock repurchased and retired during period, value for fiscal 2024 was $80.04M, a 309.17% increase from fiscal 2023.
- BIO-TECHNE Corp stock repurchased and retired during period, value for fiscal 2023 was $19.56M.
| Period end | Stock Repurchased and Retired During Period, Value 3 month | Stock Repurchased and Retired During Period, Value 12 month |
|---|---|---|
| 2026-06-30 | $41.67M 10-K · filed 2026-08-24 | |
| 2025-09-30 | $24.00K 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $277.54M 10-K · filed 2026-08-24 | |
| 2025-03-31 | $100.05M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $75.63M 10-Q · filed 2026-05-06 | |
| 2024-06-30 | $80.04M 10-K · filed 2026-08-24 | |
| 2023-12-31 | $80.04M 10-Q · filed 2025-05-08 | |
| 2023-06-30 | $19.56M 10-K · filed 2025-08-22 | |
| 2020-03-31 | $50.11M 10-Q · filed 2020-05-11 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $15.40M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |